- Home
- MRC vs ANIP Comparison
MRC vs ANIP Comparison
Compare MRC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRC
- ANIP
- Stock Information
- Founded
- MRC 1921
- ANIP 2001
- Country
- MRC United States
- ANIP United States
- Employees
- MRC N/A
- ANIP N/A
- Industry
- MRC Industrial Machinery/Components
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- MRC Industrials
- ANIP Health Care
- Exchange
- MRC Nasdaq
- ANIP Nasdaq
- Market Cap
- MRC 1.1B
- ANIP 1.3B
- IPO Year
- MRC 2012
- ANIP N/A
- Fundamental
- Price
- MRC $12.87
- ANIP $65.26
- Analyst Decision
- MRC Strong Buy
- ANIP Strong Buy
- Analyst Count
- MRC 3
- ANIP 8
- Target Price
- MRC $15.00
- ANIP $80.13
- AVG Volume (30 Days)
- MRC 517.9K
- ANIP 305.6K
- Earning Date
- MRC 08-05-2025
- ANIP 08-05-2025
- Dividend Yield
- MRC N/A
- ANIP N/A
- EPS Growth
- MRC N/A
- ANIP N/A
- EPS
- MRC N/A
- ANIP N/A
- Revenue
- MRC $2,946,000,000.00
- ANIP $674,068,000.00
- Revenue This Year
- MRC $4.95
- ANIP $30.17
- Revenue Next Year
- MRC $6.80
- ANIP $7.69
- P/E Ratio
- MRC $25.25
- ANIP N/A
- Revenue Growth
- MRC N/A
- ANIP 30.27
- 52 Week Low
- MRC $9.23
- ANIP $52.50
- 52 Week High
- MRC $15.41
- ANIP $77.00
- Technical
- Relative Strength Index (RSI)
- MRC 52.97
- ANIP 59.45
- Support Level
- MRC $12.69
- ANIP $62.81
- Resistance Level
- MRC $13.03
- ANIP $64.45
- Average True Range (ATR)
- MRC 0.30
- ANIP 1.85
- MACD
- MRC -0.03
- ANIP 0.69
- Stochastic Oscillator
- MRC 52.31
- ANIP 93.75
About MRC MRC Global Inc.
MRC Global Inc distributes pipes, valves, fittings, and other infrastructure products and services to diversified gas utility, energy, and industrial end-markets. It provides supply chain solutions, technical product service and a digital platform for customers globally. It offers a range of PVF, oilfield supply, valve automation and modification, measurement, instrumentation, and other general and specialty products. Its geographical segments include the United States and International. It generates the majority of its revenue from the United States.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.